Skip to main content
. 2022 Jan 21;8:793493. doi: 10.3389/fmolb.2021.793493

TABLE 1.

Top10 (up- and down-regulated) of differentially expressed lncRNAs in bladder cancer and adjacent tissues.

lncRNA logFC Gene_biotype pValue Padj
Up regulation
LINC00967 14.446793 lincRNA 5.85E-10 4.28E-06
AC011363.1 12.456810 antisense 5.60E-04 3.90E-02
AL161630.1 11.091121 lincRNA 1.59E-04 1.58E-02
AC009652.2 10.949296 antisense 3.31E-04 2.73E-02
LINC02466 10.930985 lincRNA 1.10E-09 4.28E-06
LINC02444 10.469231 lincRNA 7.26E-04 4.65E-02
IGFL2-AS1 9.9308545 lincRNA 1.56E-04 1.58E-02
AC007128.2 9.9225318 lincRNA 1.60E-04 1.58E-02
LINC02341 9.7206037 lincRNA 3.70E-04 2.92E-02
LINC02465 9.2758257 lincRNA 3.53E-06 1.10E-03
Down regulation
AL445465.2 −12.1814044 lincRNA 1.23E-05 0.002734055
AL136369.1 −11.9078285 antisense 8.14E-05 0.010232757
NLGN1-AS1 −11.4139638 antisense 3.43E-06 0.001101752
AC116456.1 −11.3044163 antisense 1.40E-06 0.000681887
AP003548.1 −11.0832922 lincRNA 4.96E-06 0.001434254
AL355073.2 −11.0583421 antisense 1.57E-05 0.003396762
NCAM1-AS1 −10.9532117 antisense 1.65E-06 0.000697001
AC010082.1 −10.9006501 antisense 6.32E-05 0.009137361
AP002833.1 −10.7851825 lincRNA 3.09E-04 0.025968474
PGR-AS1 −10.7221019 processed transcript 2.02E-07 0.000157829